| Particulars |
|
|
|
| Company Name
| Emcure Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
189.48 |
B.V. (₹) |
159.60 |
| Sales(₹ Cr.) |
4,381.92 |
NP (₹ Cr.) |
317.13 |
| NP Var% |
95.00 |
Div% |
30.00 |
| CPS(₹) |
28.60 |
EPS (₹) |
16.70 |
| Traded Value(₹ Lakhs) |
77.36 |
52 Week High |
1,578.00 |
| 52 Week Low |
890.00 |
Price BSE |
1,312.00 |
| Price NSE |
1,312.00 |
Market Capital (₹ Cr.) |
24,866.85 |
| P/C Ratio |
45.90 |
P/E Ratio |
78.40 |
| Price Vs.BV |
8.22 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
1,278.19 |
| NP(₹ Cr.) |
139.56 |
NP Var % |
281.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
3,847.63 |
| OPM |
12.71 |
NP |
232.25 |
| NP Var% |
95.18 |
EPS |
16.74 |
| PE |
78.40 |
|
|